fda approved semaglutide weight loss Approves Game-Changing Drug The FDA-approved GLP-1 pill for

Cardiovascular Effects in Mice Research in mice has shown that Semaglutide may reduce inflammation and oxidative stress markers associated with cardiovascular strain, highlighting its potential in heart-related studies

N Engl J Med 373(1):1122 Lean M et al (2014) Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults

Refrigeration extends shelf life for long-term storage but is not required for normal use periods

Short answer: GLP-1 medications can be used short term, but they are generally designed for ongoing weight management